Skip to search formSkip to main contentSkip to account menu

Oncotype DX Breast Cancer Assay

Known as: Oncotype DX 
A diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
6575Background: The 21-tumor gene expression assay has been shown to predict breast cancer recurrence and adjuvant chemotherapy… 
2016
2016
PurposeOncotype DX, a 21-gene expression assay, provides a recurrence score (RS) which predicts prognosis and the benefit from… 
2015
2015
It is unknown whether racial differences exist in adjuvant chemotherapy initiation among women with similar oncotype DX (ODX… 
Review
2014
Review
2014
Purpose To determine whether multiple primary breast cancers have similar genetic profiles, specifically Oncotype Dx Recurrence… 
2014
2014
Purpose The 21-gene (Oncotype DX) recurrence score (RS) assay is useful in predicting the benefits of adjuvant chemotherapy for… 
Review
2007
Review
2007
576 Background: In node-negative, ER + breast cancer, gene expression profiling can identify level of risk and, in the case of…